NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Cell and Gene Therapy Business Outlook

出版商 Kalorama Information 商品編碼 1019337
出版日期 24 Issues/Year 內容資訊 英文
細胞、基因治療商務的展望 Cell and Gene Therapy Business Outlook
出版日期: 24 Issues/Year 內容資訊: 英文

從 "INSTRUMENT BUSINESS OUTLOOK" 博得好評的Science and Medicine Group,細胞、基因治療專門的新刊登場。


  • CAGT市場市場規模與預測:每期,預測特定的治療市場區隔的市場機會的大小與未來的收益。
  • 資金籌措情形的把握:在每年幾十億美元投資發表中,誰籌措資金 (其背後的企業相關)的每期追蹤。還有定期分析資金籌措趨勢。
  • 形成明日商務的科學的新聞快報與分析:本年間資訊,以提供最新的新聞為目的。以當天的最新消息對商務來說意味什麼為焦點,嚴選的新聞和分析,不容錯過細胞、基因治療的重要發展。
  • 追蹤CAGT企業間的交易:每期的 "Recent Deals Table" ,追蹤幹細胞企業間重要的交易,及企業與產業外的企業進行的交易 (技術轉移,夥伴關係,合併,流通等) 。
  • 細胞、基因治療工具:電子報提供細胞、基因治療的製造設備和消耗品的廠商相關的開發,產品的銷售,相關交易。
Product Code: CGTBO

From Science and Medicine Group, the owners of the popular ‘INSTRUMENT BUSINESS OUTLOOK’ comes a new publication dedicated to cell and gene therapy. “Cell and Gene Therapy Business Outlook” will offer the following:

  • Market Sizing and Forecasting of CAGT Markets: Each issue sizes up the market opportunity and projects the future revenues for a given therapeutic segment.
  • Keeping an Eye on Financing: With billions of investment dollars announced each year, Cell and Gene Therapy Business Outlook tracks who is getting financed (and the companies behind the financing) each issue. On a regular basis we will analyze trends in that financing.
  • News Briefs and Analysis of the Science That will Shape Tomorrow's Business: Cell and Gene Therapy Business Outlook is designed to provide the most relevant news. With a focus on what the recent news of the day means for business, our curated news and news analysis means that you and your organization can be confident you won't miss an important development in cell and gene therapy.
  • Deals Between CAGT Companies Tracked: Each issue's "Recent Deals Table" tracks the important deals between stem cell companies as well as the deals they engage in (tech transfers, partnerships, mergers, distribution and other activities) with companies outside the industry.
  • Cell and Gene Therapy Tools: This newsletter will also report on developments, product launches and deals relating to the makers of cell and gene therapy manufacturing equipment and supplies.